<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To ensure that <z:hpo ids='HP_0000001'>all</z:hpo> Alzheimer centres across Europe are capable of using a similar method of data collection </plain></SENT>
<SENT sid="1" pm="."><plain>Information about the patient assessment tools used by each participating centre was obtained and <z:mpath ids='MPATH_458'>normal</z:mpath> clinical practice in each EADC centre was documented by collecting data from routine new patient consultation </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Twenty new consecutive patients with objective <z:hpo ids='HP_0002354'>memory impairment</z:hpo> were recruited in each Alzheimer centre over 6 months </plain></SENT>
<SENT sid="3" pm="."><plain>Each patient consultation was carried out according to routine clinical practice </plain></SENT>
<SENT sid="4" pm="."><plain>Patient data were recorded using the anonymous patient protocol (demographic, diagnosis, MMSE score, patient assessment scales, and most prominent <z:e sem="disease" ids="C0260653" disease_type="Mental or Behavioral Dysfunction" abbrv="">behavioural problem</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Information about neuropsychological assessment tools used in each centre was take to account to harmonise research practice for future multicentre collaboration </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Seven hundred and four patients from 36 memory clinics in 13 countries across Europe participated in the study </plain></SENT>
<SENT sid="7" pm="."><plain>[M:F ratio 0.67 </plain></SENT>
<SENT sid="8" pm="."><plain>Mean age 75.4 SD 9.3 (51-102) Mean MMSE 21 SD 6 (0-30)] Five hundred and fifty-five patients had a clinical diagnosis of <z:hpo ids='HP_0000726'>dementia</z:hpo> [<z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (68.5%), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (10.3%), <z:hpo ids='HP_0000727'>frontal lobe dementia</z:hpo> (5.6%), Lewy body <z:hpo ids='HP_0000726'>dementia</z:hpo> (4.1%), mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> (5.6%)] </plain></SENT>
<SENT sid="9" pm="."><plain>Duration of symptoms: 0-6 months 6.5%; 6-12 months 16.1%; 1-2 years 30.5%; 2-5 years 46.9% </plain></SENT>
<SENT sid="10" pm="."><plain>Assessment scales used: Clinical <z:hpo ids='HP_0000726'>Dementia</z:hpo> Rating (CDR) 48.9%, Reisberg's Global Deterioration Scale (GDS) 38.6%, ADL/IADL (Lawton and Brody, 1969) 37.5%, Neuropsychological Inventory (NPI) 28.6%, Geriatric <z:hpo ids='HP_0000716'>Depression</z:hpo> Scale 22%, ADL (Katz et al., 1963) 19.2%, ADAS-Cog 14.9%, Cornell Scale for <z:hpo ids='HP_0000716'>Depression</z:hpo> 12.9%, Grober and Bushke Selective Reminding Test 11.5%, ADCS/ADL 7.7% </plain></SENT>
<SENT sid="11" pm="."><plain>64.8% of the patients experienced behavioural symptoms: <z:hpo ids='HP_0000741'>apathy</z:hpo> 13.6%; <z:hpo ids='HP_0000739'>anxiety</z:hpo> 12.8%; <z:e sem="disease" ids="C0233477" disease_type="Mental or Behavioral Dysfunction" abbrv="">dysphoria</z:e> 9.9%; <z:hpo ids='HP_0000737'>irritability</z:hpo> 7.8%; <z:hpo ids='HP_0000713'>agitation</z:hpo> 5.5%; <z:hpo ids='HP_0000738'>hallucinations</z:hpo> 3.6%; <z:hpo ids='HP_0000746'>delusions</z:hpo> 3.6%, <z:e sem="disease" ids="C0851578" disease_type="Disease or Syndrome" abbrv="">sleep disorder</z:e> 2.4%; desinhibition 2% </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The most common type of <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> was <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> followed by mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>CDR, GDS Reisberg, and ADL/IADL were used widely (40-50%) </plain></SENT>
<SENT sid="14" pm="."><plain>The NPI, geriatric <z:hpo ids='HP_0000716'>depression</z:hpo> scale and ADL (Katz, 1963) were only used in 20% of the centres </plain></SENT>
<SENT sid="15" pm="."><plain>We verified large differences in the tools use in the EADC centres to evaluate patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> across Europe </plain></SENT>
<SENT sid="16" pm="."><plain>There is a need for a consensus in the use of assessment tools for <z:hpo ids='HP_0000726'>dementia</z:hpo> in Alzheimer's centres in Europe </plain></SENT>
</text></document>